Home > Insider Trading > Keryx Biopharmaceuticals Inc

Keryx Biopharmaceuticals Inc (KERX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

What Happened To Billionaire Seth Klarman's Top Biotech Picks In The Third Quarter?

Some investors think billionaire Seth Klarman is the next Warren Buffett. Given that Klarman's $31 billion fund, Baupost Group, has achieved average annual returns of 17% a year for over 30 years, ...

Keep Reading →

October 14th, 2015 - News

Two Biotech Stocks Have Been Ignoring the Crowd Today and This Metric Says They are Poised to Grow Even Further

Amid a broader market sell-off, several biotechnology stocks have surged in today’s trading session, although the industry overall has declined with the NASDAQ Biotech Index down by almost 3%.

Keep Reading →

September 24th, 2015 - Hedge Funds Market Movers News

Billionaire Klarman's Top Small-Cap Picks: ViaSat Inc., Theravance Inc., PBF Energy

The Baupost Group is a Boston-based hedge fund founded and operated by billionaire Seth Klarman.

Keep Reading →

May 22nd, 2015 - Hedge Funds News

Billionaire Seth Klarman's Biotech Stock Picks

Billionaire Seth Klarman is a notorious investor who despite his uncoventional approaches always managed to achieve high returns.

Keep Reading →

March 15th, 2015 - Hedge Funds News

Keryx Biopharmaceuticals (KERX): Baupost Group Boosts Its Stake

Seth Klarman is bullish on Keryx Biopharmaceuticals (NASDAQ:KERX) and his fund, Baupost Group, has recently surged its position in the company.

Keep Reading →

October 10th, 2014 - Hedge Funds News

Seth Klarman’s Baupost Group Continues to Bet on Tech

On Wednesday, May 14th, Seth Klarman’s Baupost Group, presented its Form 13F Filing for the first quarter of 2014 at the U.S. Securities and Exchange Commission.

Keep Reading →

May 15th, 2014 - Hedge Funds

Hedge Funds Are Crazy About Astex Pharmaceuticals, Inc. (ASTX)

In the 21st century investor’s toolkit, there are dozens of indicators shareholders can use to analyze publicly traded companies.

Keep Reading →

September 17th, 2013 - News

Amgen, Inc. (AMGN), Impax Laboratories Inc (IPXL): Keryx Biopharmaceuticals (KERX)'s Stifel Conference Presentation

There were definitely some good parts in what Keryx Biopharmaceuticals (NASDAQ:KERX) had to say at this week's Stifel Nicolaus Weisel Healthcare Conference in Boston.

Keep Reading →

September 15th, 2013 - News

What Hedge Funds Think About Kythera Biopharmaceuticals Inc (KYTH)

To the average investor, there are tons of methods market participants can use to track publicly traded companies. Two of the most useful are hedge fund and insider trading activity.

Keep Reading →

September 13th, 2013 - News

This Metric Says You Are Smart to Buy Neurocrine Biosciences, Inc. (NBIX)

In the financial world, there are dozens of indicators investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.

Keep Reading →

September 4th, 2013 - News